Matsuoka, Nakagawa, Masuda et al.: "Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer." in: Cancer research, Vol. 61, Issue 14, pp. 5362-5, 2001 (PubMed).
Lukas, Bartkova, Latella et al.: "DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology." in: Cancer research, Vol. 61, Issue 13, pp. 4990-3, 2001 (PubMed).
Falck, Mailand, Syljuåsen et al.: "The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis." in: Nature, Vol. 410, Issue 6830, pp. 842-7, 2001 (PubMed).
Hirao, Kong, Matsuoka et al.: "DNA damage-induced activation of p53 by the checkpoint kinase Chk2." in: Science (New York, N.Y.), Vol. 287, Issue 5459, pp. 1824-7, 2000 (PubMed).
Shieh, Ahn, Tamai et al.: "The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites." in: Genes & development, Vol. 14, Issue 3, pp. 289-300, 2000 (PubMed).
Matsuoka, Huang, Elledge: "Linkage of ATM to cell cycle regulation by the Chk2 protein kinase." in: Science (New York, N.Y.), Vol. 282, Issue 5395, pp. 1893-7, 1998 (PubMed).